Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Maria Diaz

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Cancer Research|May 21, 2010
Type III IFN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancerPhonphimon Wongthida, Rosa Maria Diaz, Feorillo Galivo, et al.
Journal of Clinical and Experimental Dentistry|December 12, 2019
Stem cells and oral surgery: A systematic reviewRegina Mosquera-Perez, Ana Fernández-Olavarria, Rosa-Maria Diaz-Sanchez, et al.
Human Gene Therapy|March 4, 2011
Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virusPhonphimon Wongthida, Rosa Maria Diaz, Christine Pulido, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Improved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2Timothy Kottke, Jill Thompson, Rosa Maria Diaz, et al.
Vaccines|October 26, 2024
Intranasal Prime-Boost with Spike Vectors Generates Antibody and T-Cell Responses at the Site of SARS-CoV-2 InfectionMuriel Metko, Jason Tonne, Alexa Veliz Rios, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 28, 2004
Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumorsDragan Jevremovic, Rajiv Gulati, Ivo Hennig, et al.
Cancer Research|March 9, 2005
Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivoLuis Sanchez-Perez, Timothy Kottke, Rosa Maria Diaz, et al.
Human Gene Therapy|November 20, 2009
Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virusFeorillo Galivo, Rosa Maria Diaz, Uma Thanarajasingam, et al.
Nature Medicine|September 20, 2005
Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cellsCaroline Cole, Jian Qiao, Timothy Kottke, et al.
Nature Biotechnology|March 5, 2002
Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cellsJohn Chester, Anja Ruchatz, Michael Gough, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Cancer Research|May 21, 2010
Type III IFN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancerPhonphimon Wongthida, Rosa Maria Diaz, Feorillo Galivo, et al.
Journal of Clinical and Experimental Dentistry|December 12, 2019
Stem cells and oral surgery: A systematic reviewRegina Mosquera-Perez, Ana Fernández-Olavarria, Rosa-Maria Diaz-Sanchez, et al.
Human Gene Therapy|March 4, 2011
Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virusPhonphimon Wongthida, Rosa Maria Diaz, Christine Pulido, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Improved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2Timothy Kottke, Jill Thompson, Rosa Maria Diaz, et al.
Vaccines|October 26, 2024
Intranasal Prime-Boost with Spike Vectors Generates Antibody and T-Cell Responses at the Site of SARS-CoV-2 InfectionMuriel Metko, Jason Tonne, Alexa Veliz Rios, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 28, 2004
Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumorsDragan Jevremovic, Rajiv Gulati, Ivo Hennig, et al.
Cancer Research|March 9, 2005
Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivoLuis Sanchez-Perez, Timothy Kottke, Rosa Maria Diaz, et al.
Human Gene Therapy|November 20, 2009
Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virusFeorillo Galivo, Rosa Maria Diaz, Uma Thanarajasingam, et al.
Nature Medicine|September 20, 2005
Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cellsCaroline Cole, Jian Qiao, Timothy Kottke, et al.
Nature Biotechnology|March 5, 2002
Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cellsJohn Chester, Anja Ruchatz, Michael Gough, et al.
Pageof 5